Title:
INTRANASAL TESTOSTERONE BIO-ADHESIVE GEL FORMULATIONS AND USE THEREOF FOR TREATING MALE HYPOGONADISM
Document Type and Number:
Japanese Patent JP2022105175
Kind Code:
A
Abstract:
To provide a testosterone gel formulation containing a novel active ingredient to effectively treat male subjects who are diagnosed with testosterone deficiency such as hypogonadism.SOLUTION: The inventive method involves local depositing intranasal testosterone gels topically into the nasal cavity of each nostril, to deliver a therapeutically effective amount of testosterone in smaller volumes, for providing constant effective testosterone brain and/or blood levels over a dose life, for use for testosterone replacement therapy, especially for effectively treating males in need of testosterone to treat hypogonadism.SELECTED DRAWING: None
Inventors:
WAYNE KREPPNER
SIOBHAN FOGARTY
WERNER OBEREGGER
PAUL JOSE PIERRE MARIE MAES
SIOBHAN FOGARTY
WERNER OBEREGGER
PAUL JOSE PIERRE MARIE MAES
Application Number:
JP2022076671A
Publication Date:
July 12, 2022
Filing Date:
May 06, 2022
Export Citation:
Assignee:
TRIMEL BIOPHARMA INC
International Classes:
A61K31/568; A61K9/06; A61K47/04; A61K47/14; A61K47/44; A61P5/26; A61P15/00; A61P43/00
Domestic Patent References:
JP2007524589A | 2007-08-30 | |||
JP2008522997A | 2008-07-03 |
Foreign References:
US20100311707A1 | 2010-12-09 |
Attorney, Agent or Firm:
Ryoichi Takaoka
Nao Oda
Kamoto Takahashi
Nao Oda
Kamoto Takahashi